{
  "entity_definition": {
    "issuer": "南京世和基因生物技术股份有限公司及其并表子公司",
    "related_ecosystem": "迪飞医学及其控制企业；由世和实际控制人相关主体控制，但自2022-12-28起不再并表",
    "attribution_rule": "迪飞收入、合同、装机和产品不得归入世和发行主体；仅披露为关联生态和潜在战略选项。"
  },
  "facts": [
    {
      "fact_id": "F001",
      "metric": "迪飞股权剥离",
      "value": "35.6176%股权以37,398.5320万元转让，2022-12-28完成工商变更",
      "source_id": "S001",
      "pdf_pages": "45-46",
      "text_lines": "1743-1748",
      "confidence": "A",
      "model_use": "关闭发行主体当前感染检测服务资格门；禁止把迪飞机会并入世和基准情景。"
    },
    {
      "fact_id": "F002",
      "metric": "世和感染检测资质",
      "value": "发行人无感染类检测资质；历史统一合同中的感染服务转包迪飞；剥离后未新增此类历史医院",
      "source_id": "S001",
      "pdf_pages": "377-378",
      "text_lines": "16648-16654",
      "confidence": "A",
      "model_use": "发行主体新感染临床服务SOM基准值为0；历史转包只记固定现状，不从TAM推算。"
    },
    {
      "fact_id": "F003",
      "metric": "感染相关专利归属",
      "value": "与感染类检测业务相关专利在剥离时转让给迪飞医学，2023年完成变更",
      "source_id": "S001",
      "pdf_pages": "380-381",
      "text_lines": "16745-16750",
      "confidence": "A",
      "model_use": "战略重返必须包含重新取得技术/IP/资质/产品组合的前置条件。"
    },
    {
      "fact_id": "F004",
      "metric": "发行人保有感染相关产品",
      "value": "病原体核酸序列分析软件，注册证苏械注准20222211408，有效至2027-06-30",
      "source_id": "S001",
      "pdf_pages": "252-253",
      "text_lines": "11240-11250",
      "confidence": "A",
      "model_use": "仅允许软件/分析服务小额条件性收入，不等同于mNGS检测试剂或检测服务资质。"
    },
    {
      "fact_id": "F005",
      "metric": "迪飞2025合并收入",
      "value": 66872200,
      "unit": "人民币元",
      "source_id": "S001",
      "pdf_pages": "363-364",
      "text_lines": "15907-15914",
      "confidence": "A",
      "model_use": "关联生态收入规模外部校验；未经审计且不全等于感染临床检测收入。"
    },
    {
      "fact_id": "F006",
      "metric": "迪飞2025合并净利润",
      "value": -25397200,
      "unit": "人民币元",
      "source_id": "S001",
      "pdf_pages": "363-364",
      "text_lines": "15907-15914",
      "confidence": "A",
      "model_use": "提醒生态净利为负；不得套用世和肿瘤高毛利率。"
    },
    {
      "fact_id": "F007",
      "metric": "世和向迪飞转包感染测序成本",
      "value": {
        "2023": 4232200,
        "2024": 2459400,
        "2025": 1183700
      },
      "unit": "人民币元",
      "source_id": "S001",
      "pdf_pages": "376-378",
      "text_lines": "16587-16596,16629-16654",
      "confidence": "A",
      "model_use": "固定历史转包现状观察；不随TAM参数变化。"
    },
    {
      "fact_id": "F008",
      "metric": "世和向迪飞采购设备",
      "value": "DIFLAB-96文库制备仪、DIFATS-96自动加样系统、DIFSEQ-200测序仪",
      "source_id": "S001",
      "pdf_pages": "377",
      "text_lines": "16639-16644",
      "confidence": "A",
      "model_use": "说明双方仍有平台关联交易，但产品归属迪飞，不算世和感染装机。"
    },
    {
      "fact_id": "F009",
      "metric": "剥离前感染类检测收入",
      "value": {
        "2019": 14305900,
        "2020": 21450000,
        "2021": 57193800
      },
      "unit": "人民币元",
      "source_id": "S002",
      "pdf_pages": "308-309",
      "text_lines": "13800-13815",
      "confidence": "A",
      "model_use": "历史业务锚点；2020-2021含新冠PCR，不作为mNGS市场收入。"
    },
    {
      "fact_id": "F010",
      "metric": "剥离前感染类检测量",
      "value": {
        "2019": 3700,
        "2020": 10900,
        "2021": 200100
      },
      "unit": "例",
      "source_id": "S002",
      "pdf_pages": "308-309",
      "text_lines": "13812-13825",
      "confidence": "A",
      "model_use": "2019可近似mNGS历史锚点；2020-2021受低价新冠PCR大量混入。"
    },
    {
      "fact_id": "F011",
      "metric": "剥离前感染类混合ASP",
      "value": {
        "2019": 3827.15,
        "2020": 1960.52,
        "2021": 285.83
      },
      "unit": "人民币元/例",
      "source_id": "S002",
      "pdf_pages": "309",
      "text_lines": "13821-13826,13843-13862",
      "confidence": "A",
      "model_use": "仅2019作为mNGS历史价格锚点；后两年因累计超过180万份新冠核酸而失真。"
    },
    {
      "fact_id": "F012",
      "metric": "当前发行人业务边界",
      "value": "2023-2025临床检测服务为肿瘤精准医疗口径；平均ASP与毛利率不得用于感染",
      "source_id": "S001",
      "pdf_pages": "45,283-292,363-364",
      "text_lines": "1635-1645,13045-13080,13341-13361,15864-15880",
      "confidence": "A",
      "model_use": "世和肿瘤ASP 8701/7033/6312元和临床服务毛利率不进入感染经济模型。"
    }
  ]
}